About this trial
This study is titled "Metabolomics and Biomarker Research on the Mechanism of Preoperative Sleep Disorders Affecting Postoperative Outcomes in Adult Cardiac Surgery". It aims to clarify the perioperative metabolic changes caused by preoperative sleep disorders in adult cardiac surgery patients, providing ideas for exploring the mechanism by which sleep disorders affect adverse outcomes after cardiac surgery. The study will be conducted at Fuwai Hospital, Chinese Academy of Medical Sciences. By collecting perioperative blood and fecal samples from adult cardiac surgery patients with and without preoperative sleep disorders, and simultaneously recording postoperative clinical outcome indicators (such as the incidence of delirium within 7 days after surgery, cognitive function scores, mechanical ventilation time, ICU stay time, hospital stay time, and severe cardiovascular adverse events), the study will explore the impact of preoperative sleep disorders on perioperative plasma metabolic substances, inflammatory levels, nerve damage, oxidative stress levels, and intestinal flora in adult cardiac surgery patients under general anesthesia, providing ideas and evidence for exploring the mechanism by which preoperative sleep disorders affect postoperative outcomes in adult cardiac surgery patients under general anesthesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Scheduled for elective cardiac surgery
Disqualifiers
Has a history of neurosurgery, or has suffered from neurological diseases such as cerebral hemorrhage, cerebral infarction, delirium, dementia, etc.
Has a history of mental disorders.
Heavy alcohol consumption.
American Society of Anesthesiologists (ASA) classification level IV or above.
Trial population
Adult patients scheduled for elective cardiac surgery
Trial design
Cohort
Prospective
Treatments tested in this trial
This is a observational study and there is no intervention.
Other interventionThis is a observational study and there is no intervention.
Treatment groups
Trial outcomes
Primary outcomes
Differential changes in plasma metabolic substances during the perioperative period
Secondary outcomes
Perioperative inflammatory marker levels
Perioperative nerve injury marker levels
Perioperative oxidative stress marker levels
Characteristics of the intestinal flora before the surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yan Fuxia
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Sponsor institution